{"id":16219,"date":"2026-02-06T12:05:24","date_gmt":"2026-02-06T06:35:24","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=16219"},"modified":"2026-02-06T12:05:24","modified_gmt":"2026-02-06T06:35:24","slug":"biopol-chemicals-ipo-opens-key-details-investors-shouldnt-miss","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/biopol-chemicals-ipo-opens-key-details-investors-shouldnt-miss\/","title":{"rendered":"Biopol Chemicals IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

In February 2026, investor interest in SME IPOs remained selective, with attention centred on companies operating in niche manufacturing and specialty segments. Businesses involved in specialty chemicals continued to attract interest due to their diversified end use industries, relatively higher margins, and growing demand from organised sectors such as textiles, home care, and agriculture.<\/p>\n

Against this backdrop, Biopol Chemicals Limited<\/span><\/span><\/strong> is set to open its IPO on February 6, 2026. Here is a detailed overview of Biopol Chemicals Limited, its IPO, and the industry outlook.<\/p>\n

<\/span>About Biopol Chemicals Ltd.<\/span><\/h2>\n

Incorporated in 2023, Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals categorised into silicones, emulsifiers, biochemicals, and polyelectrolytes. The company operates on a business to business model, catering primarily to institutional and industrial clients.<\/p>\n

The company has a diversified product portfolio comprising 66 products, including 40 silicone based products, 5 emulsifier based products, 15 biochemical products, and 6 polyelectrolyte products. These products find applications across multiple industries such as textiles, home care, agriculture, and industrial chemicals.<\/p>\n

Biopol Chemicals operates through four establishments located in Gujarat and West Bengal. These include its manufacturing unit, corporate office, and warehouse in West Bengal, along with its registered office in Gujarat. The manufacturing facility has an installed capacity of 18,25,000 litres per annum. As on December 31, 2025, the company employed 24 people and also reported export operations to Bangladesh.<\/p>\n

<\/span>Product Portfolio<\/span><\/h3>\n

\u2022 Textile Chemicals including softeners, silicones, emulsions, hydrophilic finishes, hardeners and binders, dyeing and printing auxiliaries
\u2022 Home Care products such as silicone fluids, emulsifiers, and cleaning chemicals
\u2022 Agriculture chemicals including silicone adjuvants and surfactants
\u2022 Industrial Chemicals such as silicone based release agents and specialty lubricants for PVC<\/p>\n

<\/span>Biopol Chemicals Ltd. IPO Details<\/span><\/h2>\n

Biopol Chemicals IPO is a book build issue of \u20b931.26 crores. The issue is entirely a fresh issue of 0.29 crore shares aggregating to \u20b931.26 crores. The IPO price band has been fixed at \u20b9102 to \u20b9108 per share, and the issue is proposed to be listed on NSE SME<\/span><\/span><\/strong>.<\/p>\n

The company intends to utilise the net proceeds from the issue towards acquisition of industrial land, repayment or prepayment of borrowings, and general corporate purposes.<\/p>\n

<\/span>Important IPO Timeline<\/span><\/h3>\n
\n
\n\n\n\n\n\n\n\n\n\n\n
Event<\/th>\nDate<\/th>\n<\/tr>\n<\/thead>\n
IPO Open Date<\/td>\nFebruary 6, 2026<\/td>\n<\/tr>\n
IPO Close Date<\/td>\nFebruary 10, 2026<\/td>\n<\/tr>\n
Allotment Date (Tentative)<\/td>\nFebruary 11, 2026<\/td>\n<\/tr>\n
Initiation of Refunds<\/td>\nFebruary 12, 2026<\/td>\n<\/tr>\n
Credit of Shares to Demat<\/td>\nFebruary 12, 2026<\/td>\n<\/tr>\n
Listing Date (Tentative)<\/td>\nFebruary 13, 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/span>Key IPO Details<\/span><\/h2>\n

Here is the table on the Biopol Chemicals Ltd. IPO Review.<\/p>\n

\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/th>\nDetails<\/th>\n<\/tr>\n<\/thead>\n
Face Value<\/td>\n\u20b910 per share<\/td>\n<\/tr>\n
Issue Price Band<\/td>\n\u20b9102 to \u20b9108 per share<\/td>\n<\/tr>\n
Lot Size<\/td>\n1,200 shares<\/td>\n<\/tr>\n
Total Issue Size<\/td>\n28,94,400 shares aggregating up to \u20b931.26 crore<\/td>\n<\/tr>\n
Fresh Issue<\/td>\n28,94,400 shares aggregating up to \u20b931.26 crore<\/td>\n<\/tr>\n
Issue Type<\/td>\nBookbuilding IPO<\/td>\n<\/tr>\n
Listing At<\/td>\nNSE SME<\/td>\n<\/tr>\n
Shareholding Pre Issue<\/td>\n79,11,000 shares<\/td>\n<\/tr>\n
Shareholding Post Issue<\/td>\n1,08,05,400 shares<\/td>\n<\/tr>\n
Market Capitalisation Pre IPO<\/td>\n\u20b9116.70 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/span>Lot Size of Biopol Chemicals Ltd. IPO<\/span><\/h2>\n

The table below outlines the lot size and investment amount for different categories of investors based on the upper price band.<\/p>\n

\n
\n\n\n\n\n\n\n\n\n\n
Application<\/th>\nLots<\/th>\nShares<\/th>\nAmount<\/th>\n<\/tr>\n<\/thead>\n
Retail Investor Min<\/td>\n2<\/td>\n2,400<\/td>\n\u20b92,59,200<\/td>\n<\/tr>\n
Retail Investor Max<\/td>\n2<\/td>\n2,400<\/td>\n\u20b92,59,200<\/td>\n<\/tr>\n
S HNI Min<\/td>\n3<\/td>\n3,600<\/td>\n\u20b93,88,800<\/td>\n<\/tr>\n
S HNI Max<\/td>\n7<\/td>\n8,400<\/td>\n\u20b99,07,200<\/td>\n<\/tr>\n
B HNI Min<\/td>\n8<\/td>\n9,600<\/td>\n\u20b910,36,800<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/span>Biopol Chemicals Ltd. Financials<\/span><\/h2>\n

Biopol Chemicals IPO has a pre issue market capitalisation of \u20b9116.70 crore. As of December 31, 2025, the company reported strong profitability metrics with a Return on Equity of 36.32 percent and a Return on Capital Employed of 26.32 percent. The Return on Net Worth stood at 30.74 percent, while the Profit After Tax margin improved to 12.29 percent. EBITDA margin for the same period was reported at 18.41 percent.<\/p>\n

Other financial details of the company are summarised below.<\/p>\n

<\/span>Key Company Financials<\/span><\/h3>\n
\n
\n\n\n\n\n\n\n\n\n\n\n\n
Period Ended<\/th>\n31 Dec 2025<\/th>\n31 Mar 2025<\/th>\n31 Mar 2024<\/th>\n<\/tr>\n<\/thead>\n
Assets<\/td>\n48.88<\/td>\n31.48<\/td>\n17.56<\/td>\n<\/tr>\n
Total Income<\/td>\n48.97<\/td>\n49.15<\/td>\n17.43<\/td>\n<\/tr>\n
Profit After Tax<\/td>\n6.00<\/td>\n4.33<\/td>\n2.96<\/td>\n<\/tr>\n
EBITDA<\/td>\n8.99<\/td>\n6.53<\/td>\n4.43<\/td>\n<\/tr>\n
Net Worth<\/td>\n19.54<\/td>\n13.53<\/td>\n9.20<\/td>\n<\/tr>\n
Reserves and Surplus<\/td>\n11.63<\/td>\n5.62<\/td>\n1.29<\/td>\n<\/tr>\n
Total Borrowing<\/td>\n14.92<\/td>\n7.69<\/td>\n3.58<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

Amount in \u20b9 crore.<\/p>\n

<\/span>Biopol Chemicals Ltd.: Industry Outlook<\/span><\/h2>\n

\u2022 Demand for specialty chemicals continues to rise across textiles, home care, agriculture, and industrial applications
\u2022 Silicone based and value added chemical products typically offer higher margins compared to commodity chemicals
\u2022 Growth in organised textile processing and home care manufacturing is supporting steady demand
\u2022 Export opportunities in neighbouring markets can provide incremental growth, though pricing and competition remain key factors
\u2022 The specialty chemicals segment remains competitive, with profitability dependent on product mix, scale, and cost control<\/p>\n

<\/span>Conclusion<\/span><\/h2>\n

Biopol Chemicals Ltd. presents an SME IPO opportunity for investors seeking exposure to the specialty chemicals segment with diversified end use industries. The company has demonstrated strong growth in revenues and profitability over recent periods and operates with a broad product portfolio catering to textiles, home care, agriculture, and industrial applications. The IPO proceeds are expected to support capacity related expansion through land acquisition, reduce leverage, and strengthen the balance sheet.<\/p>\n

However, potential investors should carefully assess risks such as the sustainability of recent performance, competitive pressures in specialty chemicals, and execution risks associated with expansion plans. As with all SME IPOs, reviewing the offer documents in detail and aligning the investment with individual risk appetite remains essential.<\/p>\n

[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n